Analysis of Biochemical Control and Prognostic Factors in Patients Treated With Either Low-Dose Three-Dimensional Conformal Radiation Therapy or High-Dose Intensity-Modulated Radiotherapy for Localized Prostate Cancer

International Journal of Radiation Oncology Biology Physics

Volumn 68, Issue 4, 2007, Pages 1053-1058

  Vora, Sujay A ^a   Wong, William W ^a   Schild, Steven E ^a   Ezzell, Gary A ^a   Halyard, Michele Y ^a  

^a MAYO CLINIC   (United States)

Author keywords

3D treatment planning; IMRT; Prostate cancer; Radiation dose

Indexed keywords

3D TREATMENT PLANNING; BIOCHEMICAL CONTROL RATE; INTENSITY MODULATED RADIOTHERAPY (IMRT); MULTIVARIATE ANALYSES; PROSTATE CANCER;

DOSIMETRY; ONCOLOGY; TOXICITY; TUMORS;

RADIOTHERAPY;

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER INVASION; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER STAGING; CHEMICAL ANALYSIS; COMPUTER ASSISTED RADIOTHERAPY; CONSENSUS; CONTROLLED STUDY; FOLLOW UP; GLEASON SCORE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PERINEUM; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; RADIATION DOSE; THREE DIMENSIONAL IMAGING; TOXICITY; TREATMENT PLANNING; UNIVARIATE ANALYSIS;

ANALYSIS OF VARIANCE; CONSENSUS; FOLLOW-UP STUDIES; HUMANS; MALE; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIATION ONCOLOGY; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 34447265271     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.01.043     Document Type: Article

References (16)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2006. CA Cancer J Clin 56 (2006) 106-130
2. Pollack A., Zagars G.K., Smith L.G., et al. Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer. J Clin Oncol 18 (2000) 3904-3911
3. Pollack A., Zagars G.K., Starkschall G., et al. Prostate cancer radiation dose response: Results of the M. D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 53 (2002) 1097-1105
4. Peeters S.T., Heemsbergen W.D., Koper P.C., et al. Dose-response in radiotherapy for localized prostate cancer: Results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. J Clin Oncol 24 (2006) 1990-1996
5. Zietman A.L., DeSilvio M.L., Slater J.D., et al. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: A randomized controlled trial. JAMA 294 (2005) 1233-1239
6. American Society for Therapeutic Radiology and Oncology Consensus Panel. Consensus statement: Guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys 37 (1997) 1035-1041
7. Roach III M., Hanks G., Thames Jr. H., et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 65 (2006) 965-974
8. Zelefsky M.J., Fuks Z., Hunt M., et al. High-dose intensity modulated radiation therapy for prostate cancer: Early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys 53 (2002) 1111-1116
9. Vlachaki M.T., Teslow T.N., Amosson C., et al. IMRT versus conventional 3DCRT on prostate and normal tissue dosimetry using an endorectal balloon for prostate immobilization. Med Dosim 30 (2005) 69-75
10. Jani A.B., Gratzle J., Muresan E., et al. Analysis of acute toxicity with use of transabdominal ultrasonography for prostate positioning during intensity-modulated radiotherapy. Urology 65 (2005) 504-508
11. Lattanzi J., McNeeley S., Donnelly S., et al. Ultrasound-based stereotactic guidance in prostate cancer-quantification of organ motion and set-up errors in external beam radiation therapy. Comput Aided Surg 5 (2000) 289-295
12. Serago C.F., Chungbin S.J., Buskirk S.J., et al. Initial experience with ultrasound localization for positioning prostate cancer patients for external beam radiotherapy. Int J Radiat Oncol Biol Phys 53 (2002) 1130-1138
13. Zelefsky M.J., Fuks Z., and Leibel S.A. Intensity-modulated radiation therapy for prostate cancer. Semin Radiat Oncol 12 (2002) 229-237
14. Wong W.W., Schild S.E., Vora S.A., et al. Association of percent positive prostate biopsies and perineural invasion with biochemical outcome after external beam radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 60 (2004) 24-29
15. Beard C., Schultz D., Loffredo M., et al. Perineural invasion associated with increased cancer-specific mortality after external beam radiation therapy for men with low- and intermediate-risk prostate cancer. Int J Radiat Oncol Biol Phys 66 (2006) 403-407
16. Zagars G.K., Pollack A., and von Eschenbach A.C. Prognostic factors for clinically localized prostate carcinoma: Analysis of 938 patients irradiated in the prostate specific antigen era. Cancer 79 (1997) 1370-1380